Repository of Research and Investigative Information

Repository of Research and Investigative Information

Hormozgan University of Medical Sciences

Melatonin and Parkinson Disease: Current Status and Future Perspectives for Molecular Mechanisms

(2019) Melatonin and Parkinson Disease: Current Status and Future Perspectives for Molecular Mechanisms. Cell Mol Neurobiol..

[img] Text
Melatonin and Parkinson Disease.pdf

Download (841kB)

Official URL: https://link.springer.com/article/10.1007/s10571-0...

Abstract

Parkinson disease (PD) is a chronic and neurodegenerative disease with motor and nonmotor symptoms. Multiple pathways are involved in the pathophysiology of PD, including apoptosis, autophagy, oxidative stress, inflammation, α-synuclein aggregation, and changes in the neurotransmitters. Preclinical and clinical studies have shown that melatonin supplementation is an appropriate therapy for PD. Administration of melatonin leads to inhibition of some pathways related to apoptosis, autophagy, oxidative stress, inflammation, α-synuclein aggregation, and dopamine loss in PD. In addition, melatonin improves some nonmotor symptom in patients with PD. Limited studies, however, have evaluated the role of melatonin on molecular mechanisms and clinical symptoms in PD. This review summarizes what is known regarding the impact of melatonin on PD in preclinical and clinical studies.

Item Type: Article
Keywords: Apoptosis; Autophagy; Melatonin; Oxidative stress; Parkinson disease
Subjects: QU Biochemistry. Cell Biology and Genetics > QU 100-133 Biochemistry of the Human Body
WL Nervous System > WL 200-405 Central Nervous System. Disorders. Therapeutics
Divisions: Research Vice-Chancellor Department > Student Research Committee
Depositing User: هدی فهیم پور
URI: http://eprints.hums.ac.ir/id/eprint/6582

Actions (login required)

View Item View Item